SHANGHAI, Feb. 11, 2023 /PRNewswire/ -- LanzaTech NZ, Inc. ("LanzaTech"), an innovative leader in c...
SHANGHAI, Feb. 10, 2023 /PRNewswire/ -- On Feb 9 Beijing time, Hesai Technology ("Hesai"), a global...
SHANGHAI, Feb. 4, 2023 /PRNewswire/ -- Qiming Venture Partners' portfolio company Structure Therape...
SHANGHAI, Jan. 31, 2023 /PRNewswire/ -- On January 25, Beijing time, QuantaSing Group Limited, a Qi...
SHANGHAI, Oct. 18, 2022 /PRNewswire/ -- Transwarp, a Qiming Venture Partners portfolio company andC...
SHANGHAI, July 25, 2022 /PRNewswire/ -- Qiming Venture Partners' portfolio company InventisBio (SHS...
SHANGHAI, July 24, 2022 /PRNewswire/ -- Qiming Venture Partners' portfolio company InventisBio (SHS...
SHANGHAI, July 11, 2022 /PRNewswire/ -- Qiming Venture Partners announced today the closing of its ...
SHANGHAI, April 13, 2022 /PRNewswire/ – Forbes released the 2022 Midas List on April 12, a ranking ...
SHANGHAI, March 30, 2022 /PRNewswire/ -- Qiming Venture Partners' portfolio company Rendu Biotechno...
SHANGHAI, March 22, 2022 /PRNewswire/ -- Qiming Venture Partners' portfolio company Arrail Group (S...
SHANGHAI, March 2, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm inC...
HONG KONG, Feb. 14, 2022 /PRNewswire/ -- Recently, Pluslife Biotech, an enterprise based in the Gre...
SHANGHAI, Jan. 7, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm inCh...
SHANGHAI, Jan. 4, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm inCh...
SHANGHAI, Dec. 10, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company CANbridge Pharma...
SHANGHAI, Nov. 15, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Aohua Endoscopy ...
SHANGHAI, Oct. 19, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Microtech Medic...
SHANGHAI, Oct. 15, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Abbisko (SEHK:22...
SHANGHAI, Sept. 24, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Broncus (SEHK:2...